A monthly injection for managing severe asthma could help patients safely reduce or even discontinue daily steroid ...

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral corticosteroids ...

Nasal vaccines offer convenience and another option for those wary of needles, but traditional vaccines are best for young ...

An education module for internal medicine residents improves counseling of patients with food allergies on the use of ...

The sizzle is the excitement about the hunt for the next big blockbuster, and the only one that anyone sees on the horizon is ...

That price equates to an aggregate equity value of $2.2 billion, according to GSK, who added that the upfront investment net ...

GSK has agreed to pay $58 per RAPT share, with an upfront payment of $1.9 billion, that will give it global rights to ...

For Tracy Owen, eczema was much more than dry skin. It came to dictate every aspect of her life, from ­relationships to how she dressed.

Pelayo was introduced to inhaled insulin by her endocrinologist, Dr. Nora Barsony. “It's a little tiny powder that goes right ...

According to a detailed report by the BBC, growing scientific evidence suggests that hypnosis can deliver real clinical benefits, sometimes outperforming conventional treatments in effectiveness, cost ...

GSK plc agreed to buy Rapt Therapeutics, a US-based biotech developing treatments for patients with inflammatory and ...